USD 1.33
(8.13%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -2.93 Million USD | 36.35% |
2022 | -4.73 Million USD | -177.21% |
2021 | -1.99 Million USD | -268.5% |
2020 | 787.68 Thousand USD | 111.25% |
2019 | 137.38 Thousand USD | -69.64% |
2018 | 1.48 Million USD | 35.03% |
2017 | 1.12 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | - USD | 100.0% |
2024 Q2 | -2.89 Million USD | 0.0% |
2023 Q3 | - USD | -100.0% |
2023 FY | - USD | 36.35% |
2023 Q1 | -963.48 USD | -143.22% |
2023 Q2 | 20 Thousand USD | 2176.11% |
2023 Q4 | 141.33 Thousand USD | 0.0% |
2022 Q4 | 2229.00 USD | 520.78% |
2022 Q2 | -1.93 Million USD | -99900.05% |
2022 FY | - USD | -177.21% |
2022 Q1 | -1933.96 USD | 99.88% |
2022 Q3 | -529.73 USD | 99.97% |
2021 Q1 | -226.00 USD | -100.02% |
2021 FY | - USD | -268.5% |
2021 Q4 | -1.67 Million USD | -188461.58% |
2021 Q3 | -890.60 USD | 99.72% |
2021 Q2 | -319.39 Thousand USD | -141221.76% |
2020 Q2 | -108.69 Thousand USD | -61292.92% |
2020 Q1 | -177.05 USD | -142.77% |
2020 Q4 | 942.08 Thousand USD | 201264.55% |
2020 FY | - USD | 111.25% |
2020 Q3 | 467.85 USD | 100.43% |
2019 Q4 | -72.93 USD | 0.0% |
2019 Q3 | -72.93 USD | -154.52% |
2019 Q2 | 133.77 USD | -0.0% |
2019 Q1 | 133.78 USD | -64.01% |
2019 FY | - USD | -69.64% |
2018 Q2 | 361.50 USD | -0.0% |
2018 FY | - USD | 35.03% |
2018 Q1 | 361.50 USD | 0.0% |
2018 Q4 | 371.73 USD | -0.0% |
2018 Q3 | 371.73 USD | 2.83% |
2017 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
CorVel Corporation | 121.35 Million USD | 102.42% |
eHealth, Inc. | -9.15 Million USD | 67.934% |
Erie Indemnity Company | 568.01 Million USD | 100.517% |
GoHealth, Inc. | 24.1 Million USD | 112.183% |
Reliance Global Group, Inc. | -8.92 Million USD | 67.087% |
Reliance Global Group, Inc. | -8.92 Million USD | 67.087% |
Willis Towers Watson Public Limited Company | 2.33 Billion USD | 100.126% |